MIT Tech

MIT Technology Review

  • The State of AI: welcome to the economic singularity

    Welcome back to The State of AI, a new collaboration between the Financial Times and MIT Technology Review. Every Monday for the next two weeks, writers from both publications will debate one aspect of the generative AI revolution reshaping global power. This week, Richard Waters, FT columnist and former West Coast editor, talks with MIT…

  • The Download: spotting crimes in prisoners’ phone calls, and nominate an Innovator Under 35

    This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. An AI model trained on prison phone calls now looks for planned crimes in those calls A US telecom company trained an AI model on years of inmates’ phone and video calls and…

  • Nominations are now open for our global 2026 Innovators Under 35 competition

    We have some exciting news: Nominations are now open for MIT Technology Review’s 2026 Innovators Under 35 competition. This annual list recognizes 35 of the world’s best young scientists and inventors, and our newsroom has produced it for more than two decades.  It’s free to nominate yourself or someone you know, and it only takes…

  • An AI model trained on prison phone calls now looks for planned crimes in those calls

    A US telecom company trained an AI model on years of inmates’ phone and video calls and is now piloting that model to scan their calls, texts, and emails in the hope of predicting and preventing crimes.  Securus Technologies president Kevin Elder told MIT Technology Review that the company began building its AI tools in…

  • The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI

    This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. What we still don’t know about weight-loss drugs Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first…